Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease-Reference-Cited by-同舟云学术

Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

Published:2023-11 Issue: Volume:167 Page:115537
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Moragrega Angela B.,Gruevska Aleksandra^ORCID,Fuster-Martínez Isabel,Benedicto Ana M.,Tosca Joan^ORCID,Montón Cristina,Victor Victor M.,Esplugues Juan V.,Blas-García Ana,Apostolova Nadezda^ORCID

Funder

Generalitat Valenciana

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

Ministerio de Ciencia, Innovación y Universidades

European Regional Development Fund

European Commission

Education Culture and Sports Department

Ministerio de Educación, Cultura y Deporte

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference31 articles.

1. Contemporary epidemiology of chronic liver disease and cirrhosis;Moon;Clin. Gastroenterol. Hepatol.,2020

2. Burden of liver diseases in the world;Asrani;J. Hepatol.,2019

3. Nonalcoholic fatty liver disease 2020: the state of the disease;Cotter;Gastroenterology,2020

4. Treating inflammation to combat non-alcoholic fatty liver disease;Wiering;J. Endocrinol.,2022

5. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice;Pradere;Hepatology,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of oridonin derivatives as novel NLRP3 inflammasome inhibitors for the treatment of acute lung injury;European Journal of Medicinal Chemistry;2024-11

2. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy;Frontiers in Cell and Developmental Biology;2024-09-05

3. Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD;Biomedicines;2024-06-29

4. The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach;Current Issues in Molecular Biology;2023-11-14